Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
102M
-
Shares change
-
+2.32M
-
Total reported value, excl. options
-
$203M
-
Value change
-
+$4.46M
-
Put/Call ratio
-
0.77
-
Number of buys
-
75
-
Number of sells
-
-66
-
Price
-
$1.99
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2022
182 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q4 2022.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102M shares
of 316M outstanding shares and own 32.24% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), VANGUARD GROUP INC (13M shares), TPG GP A, LLC (12.3M shares), BlackRock Inc. (7.3M shares), MILLENNIUM MANAGEMENT LLC (5.01M shares), MORGAN STANLEY (4.22M shares), Neuberger Berman Group LLC (3.49M shares), NORGES BANK (2.71M shares), AQR CAPITAL MANAGEMENT LLC (2.14M shares), and STATE STREET CORP (2.09M shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.